Pfizer Triple-Partners for Future mRNA Vaccines and Genetic Medicines

Pfizer CEO says omicron vaccine will be ready in March

High levels of T-cells from common cold coronaviruses can provide protection against COVID-19, an Imperial College London study published on Monday has found, which could inform approaches for second-generation vaccines.

New COVAX Results: Registry Data Reveals Safety of COVID-19 Vaccines